Brighthouse Financial (BHF) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Net income available to shareholders was $150 million for Q3 2024, down from $453 million in Q3 2023, reflecting market-driven volatility.
Adjusted earnings were $767 million, including $524 million of net favorable notable items from actuarial review and assumption changes.
Statutory combined total adjusted capital was $5.7 billion at September 30, with holding company liquid assets of $1.3 billion.
Pending reinsurance agreement for a legacy block of fixed and payout annuities is expected to close imminently, with all necessary approvals received and projected to restore the RBC ratio to the 400%-450% target range.
$215 million of common stock repurchased year-to-date through November 1, 2024, reducing shares outstanding by over 50% since 2018.
Financial highlights
Adjusted earnings, less notable items, were $243 million for Q3 2024, down from $346 million in Q2 2024 and $275 million in Q3 2023.
Net investment income was $1.29 billion, with an adjusted net investment income yield of 4.26%.
Statutory combined total adjusted capital (TAC) was $5.7 billion at September 30, up $300 million from the prior quarter.
Estimated combined RBC ratio at quarter-end was between 365% and 385%; pro forma for the reinsurance deal, it would be at the low end of the 400%-450% target range.
Year-to-date annuity sales were $7.8 billion, flat year-over-year; life insurance sales were $87 million, up 19% year-over-year.
Outlook and guidance
A reinsurance transaction is expected to close by year-end, projected to bring the pro forma RBC ratio to the low end of the 400%-450% target range under normal market conditions.
Management expects full-year 2024 corporate expenses to be lower than 2023, despite typical Q4 seasonality.
Anticipate further growth in annuities and life insurance sales.
Flow reinsurance and hedging strategy changes expected to reduce new business strain and improve RBC ratio in 2025.
Long-term statutory free cash flow disclosures planned for next year, with expectations of a ramp-up as the legacy VA block runs off.
Latest events from Brighthouse Financial
- Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 202523 Feb 2026 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Shareholders to vote on $70/share cash merger with Aquarian Holdings; board recommends approval.BHF
Proxy Filing7 Jan 2026 - Q4 2024 net income was $646M, with record annuity and life sales and strong capital metrics.BHF
Q4 202426 Dec 2025 - Shareholders to vote on $70.00 per share cash merger, with board unanimous in recommending approval.BHF
Proxy Filing23 Dec 2025 - Preliminary proxy outlines annual meeting proposals and board governance for shareholder vote.BHF
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and updated incentive plan amid strong strategic progress.BHF
Proxy Filing1 Dec 2025